BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24123713)

  • 1. High resolution integrative analysis reveals widespread genetic and epigenetic changes after chronic in-vitro acid and bile exposure in Barrett's epithelium cells.
    Bajpai M; Kessel R; Bhagat T; Nischal S; Yu Y; Verma A; Das KM
    Genes Chromosomes Cancer; 2013 Dec; 52(12):1123-32. PubMed ID: 24123713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.
    Agarwal A; Polineni R; Hussein Z; Vigoda I; Bhagat TD; Bhattacharyya S; Maitra A; Verma A
    Int J Clin Exp Pathol; 2012; 5(5):382-96. PubMed ID: 22808291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mechanism of acid and bile acid-induced DNA damage involving Na+/H+ exchanger: implication for Barrett's oesophagus.
    Goldman A; Shahidullah M; Goldman D; Khailova L; Watts G; Delamere N; Dvorak K
    Gut; 2010 Dec; 59(12):1606-16. PubMed ID: 20876775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host factors influence Barrett's carcinogenesis: findings from a mouse gastroduodenal reflux model.
    Kanai S; Mukaisho KI; Yoshida S; Taniura N; Sugihara H
    Esophagus; 2019 Jul; 16(3):264-271. PubMed ID: 30790117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.
    Luebeck EG; Curtius K; Hazelton WD; Maden S; Yu M; Thota PN; Patil DT; Chak A; Willis JE; Grady WM
    Clin Epigenetics; 2017; 9():113. PubMed ID: 29046735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
    Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
    Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
    Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
    Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
    Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic alteration of the Wnt inhibitory factor-1 promoter occurs early in the carcinogenesis of Barrett's esophagus.
    Clément G; Guilleret I; He B; Yagui-Beltrán A; Lin YC; You L; Xu Z; Shi Y; Okamoto J; Benhattar J; Jablons D
    Cancer Sci; 2008 Jan; 99(1):46-53. PubMed ID: 18005197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus.
    Huo X; Zhang HY; Zhang XI; Lynch JP; Strauch ED; Wang JY; Melton SD; Genta RM; Wang DH; Spechler SJ; Souza RF
    Gastroenterology; 2010 Jul; 139(1):194-203.e1. PubMed ID: 20303354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The molecular genetic alterations in mucosa of intestines as markers of oncologic progression and estimate of effectiveness of anti-reflux operations in patients with Barrett's esophagus].
    Osminin SV; Vetshev FP; Rudenko VV; Zaletaev DV; Khorobrykh TV; Nemtsova MV
    Klin Lab Diagn; 2016 Oct; 61(10):681-5. PubMed ID: 30615323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus.
    Stairs DB; Nakagawa H; Klein-Szanto A; Mitchell SD; Silberg DG; Tobias JW; Lynch JP; Rustgi AK
    PLoS One; 2008; 3(10):e3534. PubMed ID: 18953412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma.
    Kaz AM; Grady WM; Stachler MD; Bass AJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):473-89. PubMed ID: 26021206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barrett's metaplasia develops from cellular reprograming of esophageal squamous epithelium due to gastroesophageal reflux.
    Minacapelli CD; Bajpai M; Geng X; Cheng CL; Chouthai AA; Souza R; Spechler SJ; Das KM
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G615-G622. PubMed ID: 28336546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure.
    Hao Y; Sood S; Triadafilopoulos G; Kim JH; Wang Z; Sahbaie P; Omary MB; Lowe AW
    BMC Gastroenterol; 2007 Jun; 7():24. PubMed ID: 17597535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular origins and molecular mechanisms of Barrett's esophagus and esophageal adenocarcinoma.
    Fang Y; Chen X; Bajpai M; Verma A; Das KM; Souza RF; Garman KS; Donohoe CL; O'Farrell NJ; Reynolds JV; Dvorak K
    Ann N Y Acad Sci; 2013 Oct; 1300():187-199. PubMed ID: 24117642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations.
    Hardie LJ; Darnton SJ; Wallis YL; Chauhan A; Hainaut P; Wild CP; Casson AG
    Cancer Lett; 2005 Jan; 217(2):221-30. PubMed ID: 15617840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
    Yen CJ; Izzo JG; Lee DF; Guha S; Wei Y; Wu TT; Chen CT; Kuo HP; Hsu JM; Sun HL; Chou CK; Buttar NS; Wang KK; Huang P; Ajani J; Hung MC
    Cancer Res; 2008 Apr; 68(8):2632-40. PubMed ID: 18413730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis.
    Lee OJ; Schneider-Stock R; McChesney PA; Kuester D; Roessner A; Vieth M; Moskaluk CA; El-Rifai W
    Neoplasia; 2005 Sep; 7(9):854-61. PubMed ID: 16229808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Reflux Esophagitis to Esophageal Adenocarcinoma.
    Souza RF
    Dig Dis; 2016; 34(5):483-90. PubMed ID: 27331918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.